The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (105.95) USD. With the latest stock price at 10.78 USD, the upside of FibroGen Inc based on DCF is -1083.3%.
Based on the latest price of 10.78 USD and our DCF valuation, FibroGen Inc (FGEN) is a sell. selling FGEN stocks now will result in a potential gain of 1083.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 18.1% | 12.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (887.43) - (65.88) | (105.95) |
| Upside | -8336.0% - -711.4% | -1083.3% |